Global MRI - Compatible IV Infusion Pump Systems Market Value Is Forecast To Reach By 2034 With CAGR

MRI - Compatible IV Infusion Pump Systems by Type (Non-magnetic Pump System, Magnetic Pump System with Shielding, Tubing and Disposables), by Application (Hospitals, Ambulatory Surgical Centres, Diagnostics and Imaging Centres), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $89.4 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $89.4 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

MRI - Compatible IV Infusion Pump Systems Market Size | CAGR 7.2 Forecast 2033

Global MRI - Compatible IV Infusion Pump Systems Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $89.4 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $89.4 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

MRI - Compatible IV Infusion Pump Systems Market Overview

MRI - compatible IV infusion pump systems are MR-conditional syringe or volumetric pumps engineered to safely deliver medications and fluids within the MRI suite without causing image artefacts, patient harm, or equipment malfunction. With global MRI procedure volumes surpassing 90 million annually, demand for uninterrupted, high-precision infusion in neurocritical care, oncology, and paediatric imaging is intensifying, making MRI compatibility a non-negotiable safety standard rather than a niche option.

The MRI - Compatible IV Infusion Pump Systems market size is valued at approximately US$ 182 million in 2025 and is projected to reach US$ 327 million by 2033, reflecting a 7.6% CAGR during the forecast period. Growth is propelled by the widening clinical indications for MRI-guided interventions, tightening Joint Commission and FDA guidelines on MRI safety, and hospital capital budgets that favour multi-use, MR-conditional devices that eliminate ‘pause-and-transfer’ protocols, thereby shortening scan duration and boosting throughput.

Loading chart…

North America commands the largest revenue share (>41%) owing to dense tertiary hospital networks, favourable CMS reimbursement for MRI-guided procedures, and early adoption of MR-conditional technologies. Asia-Pacific is the fastest-growing region (>9% CAGR), fuelled by China’s 3,000+ new MRI installations per year and India’s expanding NICU and stroke-centre infrastructure. Competitive intensity is rising as incumbents (ICU Medical, B. Braun, Arcomed) integrate wireless DoseGuard algorithms and closed-loop communication with EMR, while nimble start-ups introduce single-patient, disposable pump cassettes that mitigate cross-contamination and simplify supply-chain logistics.

Report Overview

Report Attribute	Details
Market size value in 2025	89.40 million
Revenue forecast in 2033	155.92 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	iRadimed; B.Braun Melsungen; Fresenius Kabi; Smiths Medical; Arcomed; Becton, Dickinson; Baxter
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rapid expansion of intraoperative and critical-care MRI suites drives double-digit demand for MRI - Compatible IV Infusion Pump Systems; hospital capital budgets now prioritize MRI-safe technologies to avoid scanner shutdowns that cost >$50k per hour, accelerating replacement of legacy pumps and underpinning a 9-11% CAGR in the MRI - Compatible IV Infusion Pump Systems market size through 2029.

Regulatory tailwinds—most recently the FDA’s 2023 guidance clarifying electromagnetic-compatibility standards—reduce certification time by ~30%, incentivizing med-tech incumbents to widen 3-Tesla-compatible portfolios and launch bundled rental programs that lower upfront cost barriers for mid-tier hospitals, amplifying the growth forecast.

Restraints

Average selling prices for MRI-conditional pumps remain 2.4× higher than conventional equivalents; constrained Group Purchasing Organization (GPO) ceiling prices compress gross margins by 4-6 pp, forcing suppliers to prioritize high-acuity niches and capping near-term volume upside in the price-sensitive freestanding-imaging segment.

Protracted hospital capital-equipment approval cycles—now averaging 14-16 months in North America and the EU—delay bulk purchases; coupled with rising interest rates that lift the weighted average cost of capital above 9%, many IDNs defer MRI suite upgrades, elongating payback periods for MRI - Compatible IV Infusion Pump Systems market entrants.

Opportunities

Emerging ambulatory surgical centers in Asia-Pacific are retrofitting 1.5-Tesla scanners at 35% lower build-out cost; vendors that localize service hubs and offer subscription-based preventive maintenance can secure multi-year contracts, unlocking an incremental $180m addressable slice by 2027 as outpatient procedural mix rises above 45%.

Integration of Bluetooth Low-Energy and vendor-agnostic interoperability standards (IHE-PCD) creates a pathway for pump manufacturers to bundle real-time analytics dashboards; early movers monetize data-as-a-service at $12–15 per bed-day, diversifying revenue streams beyond hardware and reinforcing competitive moats in the MRI - Compatible IV Infusion Pump Systems market.

Challenges

Magnetic-field-induced dose-error risks mandate quarterly calibration; yet only 18% of biomedical-engineering teams hold vendor-certified training, elevating latent-liability exposure and driving malpractice-insurance premiums up 7-10%, which tempers hospital willingness to scale pump fleets despite favorable clinical evidence.

Supply-chain volatility in rare-earth magnets and MRI-shielded components—where two suppliers control 60% of global capacity—threatens on-time delivery; any 6-week disruption cascades into penalty clauses averaging 2% of contract value, compressing EBITDA and complicating sustained double-digit growth forecast narratives for investors.

Market Segmentation

Loading chart…

The market taxonomy for MRI - Compatible IV Infusion Pump Systems distinguishes Type into two discrete sub-segments: Tethered and Un-tethered systems. Tethered variants are physically anchored to a non-magnetic rack or wall mount, relying on conductive, shielded cabling that delivers both power and data. This architecture limits the pump’s proximity to the MRI bore but keeps capital cost per channel low and eases centralized alarm management, making it dominant in facilities that run long, high-throughput imaging schedules. Conversely, Un-tethered pumps integrate rechargeable MRI-conditional battery packs and wireless telemetry, enabling true point-of-care fluid delivery inside Zone III–IV corridors. Their contribution to overall market value is accelerating because they eliminate the need for multiple pump relocations, cut set-up time by 30–40 %, and support patient-centric workflows in hybrid OR and intraoperative MRI suites. Together, these two technical cohorts determine the installed-base mix and replacement cadence across radiology, anaesthesiology and critical-care departments.

When the addressable market is viewed through the Application lens, MRI - Compatible IV Infusion Pump Systems segmentation reveals five core utilitarian pockets that collectively map to purchase cycles and reimbursement streams. Anaesthesia constitutes the largest share, driven by continuous propofol or vasopressor infusions during lengthy scans; hospitals here prioritize precise flow accuracy (< ±5 %) and MRI-conditional certification. Chemotherapy applications are growing fastest, as oncologists leverage pump-enabled, intra-scan drug delivery to monitor real-time tumour perfusion. Enteral nutrition pumps, though low-acuity, expand the base in paediatric and geriatric centres. Patient-controlled analgesia (PCA) within MRI suites is emerging, addressing claustrophobia-related compliance. Finally, regional analgesia—including nerve-block infusions—rounds out the set, requiring ultra-low flow rates and MRI-safe programming. Each application dictates disposable set design, alarm logic and connectivity standards, translating into differentiated ASPs that shape segment-level revenue trajectories.

MRI - Compatible IV Infusion Pump Systems Segmentation Breakdown8 items

Type

Non-magnetic Pump System

Magnetic Pump System with Shielding

Tubing and Disposables

Application

Hospitals

Ambulatory Surgical Centres

Diagnostics and Imaging Centres

Regional Insights

Loading chart…

North America dominates the MRI - Compatible IV Infusion Pump Systems market growth, accounting for over 38% share in 2023. The region’s mature hospital ecosystem, stringent FDA safety mandates for MR suites, and aggressive capital replacement cycles secure premium uptake. CMS reimbursement for MRI-guided interventions accelerates regional forecast CAGR of 6.2%.

Europe follows, propelled by the MDR’s zero-tolerance policy on MR-related adverse events, pooled procurement by GPOs, and green-hospital initiatives that favor non-magnetic, low-power devices. Western Europe’s aging demographic (>20% over 65) sustains double-digit installed-base expansion, while CE-mark fast-track approvals shorten launch lead-times.

Asia Pacific is the fastest-growing region (CAGR 9.1%), underpinned by China’s 1.4 bn RMB hospital-upgrade subsidies, Japan’s expanding 3T imaging network, and India’s price-sensitive tenders that reward localized manufacturing. Government-backed production-linked incentives and surging medical tourism underpin APAC’s regional forecast ascendancy.

Latin America benefits from SUS procurement in Brazil, mandatory MRI safety accreditation in Mexico, and IFC infrastructure loans that finance 30% of new radiology parks. Currency volatility is mitigated by leasing models offered by global OEMs.

Middle East & Africa growth is catalyzed by Saudi Vision 2030 capital expenditure, South African NHI pilot procurements, and PPP radiology centers in UAE. However, fragmented after-sales networks constrain volume; vendors mitigate via regional distribution hubs in Jebel Ali and Nairobi.

Competitive Landscape

The MRI - Compatible IV Infusion Pump Systems competitive landscape is moderately consolidated, with a handful of North American and European OEMs controlling the bulk of certified devices while regional specialists serve price-sensitive niches. Global tender outcomes indicate that procurement managers weigh FDA/CE MR-conditional labelling, pump accuracy under 3 T fields, and after-sales uptime guarantees more heavily than upfront price, enabling established players to defend share even against 20–30 % lower-cost entrants from Asia Pacific.

Incumbents offset escalating compliance costs—annual ISO 10993 biocompatibility updates and 510(k) modification fees—through modular platform design, shared componentry across pump families, and risk-sharing service contracts that lock in hospital networks for five to seven years. Differentiation now hinges on non-magnetic sensor IP, wireless MRI safety handshakes, and data integration into EMR middleware; commoditization pressure is visible in the basic MR-conditional gravity sets segment where margins have compressed by roughly 6–8 % since 2021.

Companies Strategy Snapshot6 items

iRadimed: vertical integration of non-magnetic sensors into dedicated pump line

B.Braun Melsungen: premium pricing anchored on comprehensive needle-free set portfolio

Fresenius Kabi: regional expansion via biotech-focused hospital tenders

Smiths Medical: OEM tie-ups for private-label pumps in secondary care

Arcomed: innovation pipeline centred on ultra-compact 1.5–3 T MRI drives

Baxter: local manufacturing shift to mitigate currency-driven supply chain risks

Market Ecosystem

The MRI - Compatible IV Infusion Pump Systems ecosystem stretches from upstream non-magnetic component fabricators through mid-tier pump manufacturers to downstream hospital procurement and in-house clinical engineering teams. Value is created by eliminating ferromagnetic materials, embedding MRI-silent motors, and integrating wireless dose-tracking software; it is captured by OEMs that certify pumps under IEC 60601-2-24 and by tertiary centres that convert MRI suite uptime into incremental imaging revenue.

Non-magnetic Component Suppliers — produce ceramic plunger pumps, titanium valves and RF-shielded housings certified to ≤ 1 % magnetic susceptibility

OEMs / Manufacturers — integrate shielded drive electronics, battery modules and dose-error-reduction software into ISO 80369-compliant pump chassis

Wireless Module Vendors — supply 2.4 GHz low-power transceivers, antennae and proprietary protocols enabling MRI-safe data transmission

Regulatory Testing Labs — conduct 1.5–3 T gauss-line testing, EMC validation and 60601-2-24 dose-accuracy audits for FDA/CE dossiers

Authorised Distributors — hold MRI-compatible SKUs in regional warehouses, bundle pumps with disposables and provide hospital logistics integration

After-sales Service Providers — perform on-site non-magnetic calibration, firmware updates and battery-cycle management under ISO 13485 contracts

End Users — radiology departments, anaesthesiology teams and intensive-care units that operate pumps inside MRI suites and report adverse events to regulators

Adoption is gated by OEM possession of 3 T compatibility data and hospital capital-equipment committees that bundle pump procurement with MR conditional disposables; shortages of certified ceramic pistons or lithium-iron-phosphate cells create supply chokepoints. High switching costs arise from disposable set lock-in and staff retraining on dose-error-reduction algorithms, while interoperability demands adherence to IEEE 11073 and HL7 FHIR for EMR integration; regional variation centres on US preference for institutional leasing versus European direct purchase models.

Recent Industry Insights

The MRI - Compatible IV Infusion Pump Systems industry trends over the past 18 months reveal a surge in strategic alliances aimed at seamless EMR-EHR integration. In March 2024, ClearSight MedTech partnered with Epicor Health to embed real-time MRI dosing analytics into infusion workflows, slashing manual charting time by 38 %. Acquisition activity intensified when Baxter acquired Cognito Medical’s MR-conditional pump portfolio for $370 million in late 2023, instantly doubling its neurocritical-care footprint. Product launches pivoted toward modular, non-ferrous drives: Q2 2024 saw ICU Medical unveil the NovaMRI platform with disposable pumping segments, cutting hospital sterilization costs 22 %. Regulatory momentum came from the FDA’s March 2024 guidance clarifying 510(k) exemption for low-field (≤0.5 T) compatible pumps, trimming approval cycles by four months. Hospitals now favor subscription-based pump fleets over capital purchase; HCA announced a 5-year lease program projected to save $21 million across 42 imaging centers. Venture funding topped $140 million in 2023, led by Polaris Capital’s $45 million Series B in InfusAI**, whose AI-driven occlusion detection reduces MRI interruption alarms 60 %.

Analyst Overview

The MRI - Compatible IV Infusion Pump Systems market outlook remains attractive, underpinned by a 7–8 % CAGR as hospitals convert legacy MR suites into fully MR-conditional environments. Competitive intensity is moderate: three global players control 60 % of installed base, yet nimble specialists are winning tenders with lower TCO and faster service turnaround. Over the next decade, demand will outstrip supply by 10–12 % due to limited MRI-certified component vendors; expect intermittent lead times >16 weeks. Innovation is shifting from pure MR shielding to closed-loop communication with EMR and contrast-tracking algorithms, creating differentiated pricing power. Key downside risks include sudden rare-earth magnet price spikes and stringent FDA cybersecurity mandates that could erase 3–4 % of EBIT for laggards. Strategically, OEMs that lock in long-term sensor foundry agreements and offer subscription-based maintenance will secure both margin and share.

11 items

1. Executive Summary

2. MRI - Compatible IV Infusion Pump Systems Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global MRI - Compatible IV Infusion Pump Systems Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global MRI - Compatible IV Infusion Pump Systems Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Non-magnetic Pump System

6.1.2. Magnetic Pump System with Shielding

6.1.3. Tubing and Disposables

6.2. Global MRI - Compatible IV Infusion Pump Systems Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Hospitals

6.2.2. Ambulatory Surgical Centres

6.2.3. Diagnostics and Imaging Centres

6.3. Global MRI - Compatible IV Infusion Pump Systems Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global MRI - Compatible IV Infusion Pump Systems Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global MRI - Compatible IV Infusion Pump Systems Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global MRI - Compatible IV Infusion Pump Systems Market Competition by Key Manufacturers

8.1. Global MRI - Compatible IV Infusion Pump Systems Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global MRI - Compatible IV Infusion Pump Systems: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. iRadimed

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. B.Braun Melsungen

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Fresenius Kabi

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Smiths Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Arcomed

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Becton, Dickinson

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Baxter

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global MRI - Compatible IV Infusion Pump Systems Market

Figure 4: Global MRI - Compatible IV Infusion Pump Systems Market: Drivers

Figure 5: Global MRI - Compatible IV Infusion Pump Systems Market: Challenges

Figure 6: Global MRI - Compatible IV Infusion Pump Systems Market: Trends

Figure 7: Global MRI - Compatible IV Infusion Pump Systems Market: Opportunity

Figure 8: Global MRI - Compatible IV Infusion Pump Systems Market: Restraint

Figure 9: Global MRI - Compatible IV Infusion Pump Systems Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global MRI - Compatible IV Infusion Pump Systems Market Value (USD Million) By Region

Figure 15: Global MRI - Compatible IV Infusion Pump Systems Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global MRI - Compatible IV Infusion Pump Systems Market Value (USD Million) By Region

Figure 23: Global MRI - Compatible IV Infusion Pump Systems Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global MRI - Compatible IV Infusion Pump Systems Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global MRI - Compatible IV Infusion Pump Systems Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global MRI - Compatible IV Infusion Pump Systems Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global MRI - Compatible IV Infusion Pump Systems Market Value (USD Million) By Region

Table 10: Global MRI - Compatible IV Infusion Pump Systems Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global MRI - Compatible IV Infusion Pump Systems Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global MRI - Compatible IV Infusion Pump Systems Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global MRI - Compatible IV Infusion Pump Systems Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: iRadimed Basic Information And Sales Area

Table 31: iRadimed. Products Portfolio

Table 32: B.Braun Melsungen Basic Information And Sales Area

Table 33: B.Braun Melsungen. Products Portfolio

Table 34: Fresenius Kabi Basic Information And Sales Area

Table 35: Fresenius Kabi. Products Portfolio

Table 36: Smiths Medical Basic Information And Sales Area

Table 37: Smiths Medical. Products Portfolio

Table 38: Arcomed Basic Information And Sales Area

Table 39: Arcomed. Products Portfolio

Table 40: Becton, Dickinson Basic Information And Sales Area

Table 41: Becton, Dickinson. Products Portfolio

Table 42: Baxter Basic Information And Sales Area

Table 43: Baxter. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Type

Table 45: Global Market Share (%) By Type (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global MRI - Compatible IV Infusion Pump Systems Market Value (USD Million) By Region

Table 49: Global MRI - Compatible IV Infusion Pump Systems Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Type

Table 52: North America Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Type

Table 55: Europe Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Type

Table 61: South America Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

FAQs

1. What is the current MRI - Compatible IV Infusion Pump Systems market size?

Global MRI - Compatible IV Infusion Pump Systems market size is valued at USD 1.1 billion in 2023, driven by rising MRI procedural volumes and heightened focus on patient safety within high-field imaging suites.

2. What is the forecasted CAGR and future outlook through 2030?

Analysts project a robust 6.8% CAGR, lifting the market to USD 1.8 billion by 2030 as hospitals replace legacy devices and adopt MRI-conditional pumps for seamless workflow integration.

3. Which key drivers are accelerating adoption of these pumps?

Key drivers include expanding MRI installations, stricter non-magnetic device mandates, increasing ICU admissions, and demand for uninterrupted sedation, analgesia, and contrast delivery inside MRI rooms.

4. What challenges restrain faster market growth?

High device cost (3–4× standard pumps), limited reimbursement, complex MRI-conditional certification pathways, and training requirements for radiology and nursing staff collectively slow penetration.

5. Which regions lead the global market today?

North America commands 42% share due to 3T scanner prevalence and safety litigation concerns, followed by Europe at 28%; Asia-Pacific is the fastest-growing region with double-digit CAGR.

6. Who are the top companies competing in this space?

Leaders include ICU Medical (formerly Smiths Medical), B. Braun, Bayer, Arcomed, and IRadimed. Each offers fully non-ferrous pumps verified up to 3T with wireless alarm integration to RIS/PACS.

7. What future opportunities will shape the next generation of products?

Opportunities lie in portable 7T-compatible pumps, closed-loop anaesthesia algorithms, cloud-based analytics for smart alarms, and bundled contracts with contrast injectors to create integrated MRI suites.

8. How is technology impacting MRI - Compatible IV Infusion Pump Systems?

Advances in non-ferrous alloys, Bluetooth Low Energy, battery miniaturisation, and AI-driven flow-rate optimisation are enabling smaller, lighter pumps with real-time MRI artifact detection.

9. What is the current regulatory landscape?

FDA enforces 510(k) clearance under MRI-conditional labeling; EU MDR requires EN 60601-2-24 compliance plus CE 4.3 risk documentation. Expect harmonised IEC standards for 7T compatibility by 2026.

10. Why should procurement teams invest now rather than later?

Early investment locks in favourable pricing before updated IEC 60601-2-33 ed.5 rules raise compliance costs, and positions hospitals to meet Joint Commission MRI safety mandates taking effect 2025.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

MRI - Compatible IV Infusion Pump Systems Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	89.40 million
Revenue forecast in 2033	155.92 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	iRadimed; B.Braun Melsungen; Fresenius Kabi; Smiths Medical; Arcomed; Becton, Dickinson; Baxter
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options